Institute for Digestive Health & Liver Diseases, Mercy Medical Center, Baltimore, Maryland, United States of America.
Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
PLoS One. 2020 Dec 31;15(12):e0244744. doi: 10.1371/journal.pone.0244744. eCollection 2020.
Hispanics are the fastest growing population in the USA, and our objective was to determine their waitlist mortality rates, liver transplantation (LT) rates and post-LT outcomes.
All adults listed for LT with the UNOS from 2002 to 2018 were included. Competing risk analysis was performed to assess the association between ethnic group with waitlist removal due to death/deterioration and transplantation. For sensitivity analysis, Hispanics were matched 1:1 to Non-Hispanics using propensity scores, and outcomes of interest were compared in matched cohort.
During this period, total of 154,818 patients who listed for liver transplant were involved in this study, of them 23,223 (15%) were Hispanics, 109,653 (71%) were Whites, 13,020 (8%) were Blacks, 6,980 (5%) were Asians and 1,942 (1%) were others. After adjusting for differences in clinical characteristics, compared to Whites, Hispanics had higher waitlist removal due to death or deterioration (adjusted cause-specific Hazard Ratio: 1.034, p = 0.01) and lower transplantation rates (adjusted cause-specific Hazard Ratio: 0.90, p<0.001). If Hispanics received liver transplant, they had better patient and graft survival than Non-Hispanics (p<0.001). Compared to Whites, adjusted hazard ratio for Hispanics were 0.88 (95% CI 0.84, 0.92, p<0.001) for patient survival and 0.90 (95% CI 0.86, 0.94, p<0.001) for graft survival. Our analysis in matched cohort showed the consistent results.
This study showed that Hispanics had higher probability to be removed from the waitlist due to death, and lower probability to be transplanted, however they had better post-LT outcomes when compared to whites.
西班牙裔是美国增长最快的人口群体,我们的目标是确定他们的候补名单死亡率、肝移植(LT)率和 LT 后的结果。
本研究纳入了 2002 年至 2018 年期间 UNOS 登记的所有成人 LT 候补患者。采用竞争风险分析评估种族与因死亡/恶化而从候补名单中删除和移植之间的关联。为了进行敏感性分析,使用倾向评分对西班牙裔进行 1:1 匹配非西班牙裔,并在匹配队列中比较感兴趣的结局。
在此期间,共有 154818 名患者参与了这项研究,其中 23223 名(15%)是西班牙裔,109653 名(71%)是白人,13020 名(8%)是黑人,6980 名(5%)是亚洲人,1942 名(1%)是其他人。在调整了临床特征差异后,与白人相比,西班牙裔因死亡或恶化而被删除的比例更高(调整后的特定原因风险比:1.034,p=0.01),移植率更低(调整后的特定原因风险比:0.90,p<0.001)。如果西班牙裔接受了肝移植,他们的患者和移植物存活率优于非西班牙裔(p<0.001)。与白人相比,西班牙裔的调整后的危险比为患者存活率 0.88(95%CI 0.84,0.92,p<0.001),移植物存活率 0.90(95%CI 0.86,0.94,p<0.001)。在匹配队列中的分析显示了一致的结果。
本研究表明,西班牙裔因死亡而被从候补名单中删除的可能性更高,移植的可能性更低,但与白人相比,他们的 LT 后结局更好。